S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from
dividing so they stop growing or die. Monoclonal antibodies, such as trastuzumab, can locate
tumor cells and either kill them or deliver tumor-killing substances to them without harming
normal cells. Colony-stimulating factors, such as filgrastim, may help a person's immune
system recover from the side effects of chemotherapy.
PURPOSE: Phase II trial to study the effectiveness of combining trastuzumab with docetaxel,
vinorelbine, and filgrastim in treating women who have stage IV breast cancer.